Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 92437
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.92437
Figure 3
Figure 3 Prospective molecular mechanisms of transmembrane protein 106C underlying pan-cancers. A: Gene set enrichment analysis was conducted across 33 cancer types to rank the enriched transmembrane protein 106C (TMEM106C) pathways; B-E: Gene set enrichment analysis results for TMEM106C in adrenocortical carcinoma, bladder cancer, breast cancer, and hepatocellular carcinoma, respectively. ECM: Extracellular matrix.